EXPERT: CLINICAL GUIDANCE RETAINS SOME PART 11 RULES

Devices & Diagnostics Letter
KEYWORDS Clinical Trials / FDA
A A

Despite appearances to the contrary, it is important to realize the FDA’s latest guidance on computer systems used in clinical trials reaffirms the agency’s intent to enforce the use of 21 CFR Part 11 in certain areas, according to an industry consultant.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00